Bankrupt Insys Plans Fentanyl Spray Sale To Competitor

By Chris Villani · September 3, 2019, 10:07 AM EDT

Bankrupt drugmaker Insys Therapeutics Inc. has reached a deal to sell the fentanyl spray painkiller that spawned its legal and financial troubles to Wyoming-based BTcP Pharma, which makes its own fentanyl...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Case Information

Case Title

Insys Therapeutics, Inc.

Case Number

1:19-bk-11292

Court

Delaware

Nature of Suit

Date Filed

June 10, 2019